Quantcast

Latest Nebulizer Stories

2011-03-21 07:15:00

RICHMOND, Va., March 21, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSMD), a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of ARIKACE(TM) (liposomal amikacin for inhalation) in nontuberculous mycobacteria (NTM) lung infections has been cleared by the U.S. Food and Drug Administration (FDA). In 2010, Insmed initially submitted a regulatory filing to FDA requesting clearance to...

2011-03-09 00:00:27

Medical Support Products Inc has launched a new ecommerce website to help customers quickly find and order respiratory equipment and supplies. Mountville, PA (PRWEB) March 8, 2011 Medical Support Products Inc has launched a new ecommerce website to help customers quickly find and order the respiratory equipment and supplies that they need. Medical Support Products offers a full line of products for respiratory care including: Medical Air Compressors, Airway Supplies and Monitors, BiPAP...

2011-02-09 08:00:00

MIDLOTHIAN, Va., Feb. 9, 2011 /PRNewswire/ -- Today, PARI Respiratory Equipment launched an updated company website at www.pari.com. In addition to providing visitors with a beautiful new interface, the website includes easy access to: Continuing Education classes Product instructional videos Frequently asked questions and answers for patients Product instructions for use Information on how to access and differentiate between various types of nebulizers, compressors, holding chambers,...

2011-01-10 07:00:00

SAN FRANCISCO, Jan. 10, 2011 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today during the JP Morgan 29th Annual Healthcare Conference, announced that it has initiated its Phase 3 clinical trial program with Aeroquin(TM) (MP-376) for the treatment of pulmonary infections in patients with cystic fibrosis (CF). Aeroquin is Mpex's proprietary aerosol formulation of levofloxacin, an antibiotic that has potent activity against key bacterial pathogens in CF including Pseudomonas aeruginosa. The...

2010-12-02 06:00:00

RICHMOND, Va., Dec. 2, 2010 /PRNewswire-FirstCall/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that it has entered into a business combination, effective immediately, with Transave, Inc., a privately-held, NJ-based biopharmaceutical company focused on the development of differentiated, innovative inhaled pharmaceuticals for the site-specific treatment of serious lung infections. Under the terms of the merger agreement, Insmed acquired all of the...

2010-11-17 00:01:11

Bruderman Brothers, Inc. to provide sell-side advisory services to a distributor and provider of home medical equipment and respiratory therapy products and services. New York, NY (Vocus) November 16, 2010 Bruderman Brothers is pleased to announce that it has been engaged to provide sell-side advisory services to a Pennsylvania-based, privately-owned, JCAHO-accredited regional distributor and provider of home medical equipment and respiratory therapy products and services. This...

2010-10-21 10:30:00

MONMOUTH JUNCTION, N.J., Oct. 21 /PRNewswire/ --Transave, Inc., today reported positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that is entering Phase III development for the treatment of chronic lung infections. The results demonstrate significant clinical benefit and complete the company's Phase II program for the treatment of lung infections due to the bacterium, Pseudomonas aeruginosa in cystic fibrosis...

2010-09-16 17:48:32

There is no apparent link between asthma and tooth decay, according to a study published in the September 2010 issue of the Journal of the American Dental Association. "Is There a Relationship between Asthma and Dental Caries?: A Critical Review of the Literature" examined the 27 separate studies which looked for a link between asthma and cavities that were reported in 29 papers published between 1976 and March 2010. "The notion that there is a link between asthma and tooth decay may have its...

2010-06-21 11:56:00

MONTEREY, Calif., June 21 /PRNewswire/ -- In a head-to-head, Phase III clinical trial of Cayston delivered by the Altera Nebulizer System versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa, the co-primary endpoint of non-inferiority for mean percent change in forced expiratory volume in one second (FEV(1)) percent predicted after 28 days of treatment was achieved. Patients receiving Cayston had a mean increase in FEV(1) percent predicted from...

2010-06-17 12:22:00

MONMOUTH JUNCTION, N.J., June 17 /PRNewswire/ -- Transave, Inc., today reported interim results from a multi-cycle Phase II open label clinical trial in cystic fibrosis (CF) patients on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The data indicated that ARIKACE, delivered once daily for 28 consecutive days followed by 56 days off-treatment for four cycles demonstrated statistically significant improvement in lung function that was sustained during the...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related